In Study, MD Anderson Team IDs Protein Marker That Detects Pancreatic Cancer With 100 Percent Accuracy | GenomeWeb

NEW YORK (GenomeWeb) – A team led by researchers at the University of Texas MD Anderson Cancer Center has identified a protein marker that in initial studies appears to detect pancreatic cancer with 100 percent accuracy.

The finding, detailed in a study published today in Nature, offers the potential for better early detection of the disease, which could significantly improve patient outcomes, Raghu Kalluri, an MD Anderson researcher and senior author on the paper, told GenomeWeb.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.